Pharma BD Deal Intelligence
BASF Chairman Jurgen Strube framed the deal as combining the two crop protection businesses to strengthen North/South American presence; combined 1999 sales…
BASF paid the Company $3.8 billion in cash and assumed certain debt. The Company recorded an after-tax loss on the sale of this business of $1,573.0 million or…
BASF acquired American Cyanamid's agricultural division from AHP in 2000, a divestiture that completed AHP's pharma refocus and positioned BASF as a top-three…
Source summaries from our enrichment pipeline; follow links for originals.
All 6 sources with sentiment breakdown →
American Home Products sold its Cyanamid Crop Protection agricultural business to BASF for ~$3.8B in cash, completing portfolio refocus on pharmaceuticals (later renamed Wyeth in 2002). NOT pharma — flagged borderline; included for transparency on AHP/Wyeth strategic direction during the 2000 mega-merger era.
Assessment window: 10yr post-close.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| American Home Products Corporation / BASF AG (Cyanamid agricultural divestiture) (this deal) | 2000 | $3.8B | 78 |
| American Home Products Corporation / American Cyanamid Company | 1994 | $9.7B | 83 |
| Watson Pharmaceuticals (Actavis Inc.) / Actavis plc | 2012 | $5.9B | 97 |
| Kohlberg Kravis Roberts & Co. / PRA International (Genstar Capital) | 2013 | $1.3B | 91 |
| Stryker Corporation / MAKO Surgical Corp. | 2013 | $1.6B | 91 |
| Quintiles Transnational Holdings Inc. / IMS Health Holdings, Inc. | 2016 | $17.6B | 91 |
| DPx Holdings B.V. (JLL Partners 51% / Royal DSM 49%) / Patheon Inc. + DSM Pharmaceutical Products | 2013 | $2.6B | 90 |
← Browse all deals · How we score deals
More: 2000 deals · Other deals